Overview of SFDA Conditional Approval for New MedicinesBy Madiha Baaj|02/12/2024|Pharmaceuticals, Regulatory Affairs|
SFDA Drug Pricing Rules in Saudi ArabiaBy Rawd Alsubaie|30/11/2024|Pharmaceuticals, Regulatory Affairs|
Reporting Medical Device Incidents & Adverse Events to SFDABy Heba Rasheed|23/02/2024|Medical Devices, Regulatory Affairs|
Breakthrough Medicines Designation in SFDABy Madiha Baaj|12/02/2024|Pharmaceuticals, Regulatory Affairs|